Rixathon 100 mg/10 ml, Konzentrat zur Herstellung einer Infusionslösung
7680664350012
CH-66435
Konzentrat
Associated product:
RIXATHON conc perf 100 mg/10ml 2 amp 10 ml
1 / 3
google
Article details
- Package size
- 2
- Selling units
- 2
- Measure
- Durchstechflasche(n)
- Galenic form
- Konzentrat
- Galenic group
- Tinkturen/Desinfektion
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
100.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 475.35
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/09/2018
Authorization holder
Sandoz Pharmaceuticals AG
6343 Risch
Authorization information
- Swissmedic authorization number
- 66435
- Drug name
- Rixathon, Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- KOPA
- ATC Code
- L01FA01
- Authorization status
- Z
- Dispensing category
- A
- First authorization
- 03/07/2018
- Authorization expiration date
- 31/12/9999
- IT Number
- 07.16.1.
- Domain
- Human medicine
Package details
- Description (FR)
- RIXATHON conc perf 100 mg/10ml 2 amp 10 ml
- Description (DE)
- RIXATHON Inf Konz 100 mg/10ml 2 Amp 10 ml
- Market launch
- 03/07/2018
- Narcotic (BTM)
- No
Other package sizes (3)
None
3 DUR
GTIN: None
RIXATHON conc perf 500 mg/50ml amp 50 ml
1 DUR
GTIN: 7680664350036
None
2 DUR
GTIN: None